Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nadezhda A. Krylova"'
Publikováno v:
Relevant lines of scientific research: theory and practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52b044d7266635e65d93addbba12e026
https://doi.org/10.21661/r-541293
https://doi.org/10.21661/r-541293
Publikováno v:
Defect and Diffusion Forum. 380:98-106
In order to describe helium atom motion through the disordered quartz structure the local chain approach is used. The number of local chains equals the number of nearest neighbours (i.e., the closest atoms to those selected). Each local chain include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6f8670aaa89e2e4d7ff283f24f9db81
https://doi.org/10.4028/www.scientific.net/ddf.380.98
https://doi.org/10.4028/www.scientific.net/ddf.380.98
Publikováno v:
Вестник московского государственного областного университета. Серия: Физика-математика, Iss 3, Pp 53-67 (2017)
The motion of the helium atom through a disordered quartz structure, described by the local chain approximation, is investigated. The number of local chains is equal to the number of nearest neighbours surrounding the He atom. Each local chain includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48d440623740494bc4f73ceea2ed55e
https://doi.org/10.18384/2310-7251-2017-3-53-67
https://doi.org/10.18384/2310-7251-2017-3-53-67
Autor:
Adel F Urmancheyeva, Alexandr V. Togo, Nadezhda Yu Krylova, Oksana S Lobeiko, Maxim E. Rozanov, Madina M. Gergova, Anna P. Sokolenko, Evgeny N. Imyanitov, Natalia V. Mitiushkina, Tatiana V Porhanova, Aglaya G. Iyevleva, Sergey Ya Maximov
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, Vol 4, Iss 4, Pp 193-196 (2006)
Hereditary Cancer in Clinical Practice, Vol 4, Iss 4, Pp 193-196 (2006)
The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of BRCA1 4153delA heterozygosity in familial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9454b5e2abf9b07b4039ebce56a4c7a9
http://europepmc.org/articles/PMC2837308
http://europepmc.org/articles/PMC2837308
Autor:
Sergei E. Sychevsky, Valery I. Afanasiev, E. A. Lamzin, Nadezhda A. Krylova, V. A. Belyakov, A.V. Belov, Darya N. Arslanova, B. V. Lyublin, Sergei Ya. Petrov, Tatiana F. Belyakova, Igor V. Kedrov, E.I. Gapionok, V. P. Kukhtin, Yury V. Zuev
Publikováno v:
2014 20th International Workshop on Beam Dynamics and Optimization (BDO).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d4553c81db9a293f480b724764bfb0d
https://doi.org/10.1109/bdo.2014.6889997
https://doi.org/10.1109/bdo.2014.6889997
Autor:
Oksana S Lobeiko, Anna Szymańska, Jakub Lubiński, Evgeny N. Imyanitov, Anna P. Sokolenko, P. Magnowski, K. Gugała, Krzysztof Mędrek, Jolanta Szymańska-Pasternak, S. Gozdz, Bohdan Górski, I. Dziuba, Steven A. Narod, Cezary Cybulski, Debniak B, Nadezhda Yu Krylova
Publikováno v:
Gynecologic Oncology. 102:429-431
Objective. Three founder alleles of the CHEK2 gene have been associated with predisposition to a range of cancer types in Poland. Two founder alleles (1100delC and IVS2 + 1G > A) result in a truncated CHEK2 protein and the other is a missense substit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01dc59ecdaca259436440658f4970534
https://doi.org/10.1016/j.ygyno.2006.05.040
https://doi.org/10.1016/j.ygyno.2006.05.040
Autor:
Evgeny N. Suspitsin, Evgeny N. Imyanitov, Tatyana Gorodnova, Anna P. Sokolenko, Nathalia V. Porhanova, Matsko De, Aglaya G. Iyevleva, Sergey Ya Maximov, Adel F Urmancheyeva, Daria N. Ponomariova, Grigory A Shiyanov, Alexandr V. Togo, Nathalia Yu. Sherina, Nadezhda Yu Krylova, Olga A. Zaitseva, Olga S. Yatsuk, Nathalia N. Tkachenko, Oksana S Lobeiko
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 7, Iss 1, p 5 (2009)
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice
Background A significant portion of ovarian cancer (OC) cases is caused by germ-line mutations in BRCA1 or BRCA2 genes. BRCA testing is cheap in populations with founder effect and therefore recommended for all patients with OC diagnosis. Recurrent m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb75edd948436288b842d80d8aa2018
http://www.hccpjournal.com/content/7/1/5
http://www.hccpjournal.com/content/7/1/5
Autor:
Nadezhda Yu Krylova, Adel F Urmancheyeva, Alexandr V. Togo, Natalia V Porhanova, Natalia Yu. Sherina, Evgeny N. Imyanitov, Natalia Yu Ogorodnikova, Daria N. Ponomariova, Oksana S Lobeiko, Evgeny N. Suspitsin, Denis A Logvinov, Sergey Ya Maximov
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, Vol 5, Iss 3, Pp 153-156 (2007)
Hereditary Cancer in Clinical Practice, Vol 5, Iss 3, Pp 153-156 (2007)
BRCA1 and BRCA2 germ-line mutations occur in a significant number of unselected ovarian cancer (OC) patients, thus making a noticeable contribution to OC morbidity. It is of interest whether CHEK2, which is frequently regarded as a third breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c8f739bf72abf5bb48d5503ecfb092